Chalabianloo, Fatemeh https://orcid.org/0000-0003-1242-1972
Fadnes, Lars Thore
Assmus, Jörg
Mordal, Jon
Solli, Kristin K.
Dale, Kjetil S.
Andersen, Christina D.
Zavenova, Silvia
Rønning, Beathe H.
Blomkvist, Andreas W.
Ryssdal, Martin
Butt, Wasifa S. J.
Marciuch, Anne
Ørmen, Anne G.
Ohldieck, Christian
Løberg, Else-Marie
Johansson, Kjell Arne
,
Mellingen, Svanhild
Olsvold, Maria K.
Nordbotn, Mette H.
Trettenes, Beate H.
Berger, Tine U.
Sannerud, Kristin
Sundal, Christine
Pierron, Marianne
Moe, Henriette
Alibhai, Zainab
Helgøy, Karoline N.
Vedaa, Susanne
Holtan, Line
Kristiansen, Heidi F.
Haugen, Britt K.
Karlsen, Jeanine T.H.
Kaspersen, Richard
Digranes, Linn C.W.
Funding for this research was provided by:
University of Bergen
Article History
Received: 10 August 2024
Accepted: 10 December 2024
First Online: 2 January 2025
Declarations
:
: The study is approved by regional ethical committee (Reference number 345516- REK Vest) and drug administration authorities in Norway and registered at www.clinicaltrials.gov. Written informed consent will be obtained from all the participants before commencing to the study.
: This manuscript does not contain individual personal data and the participants have given written informed consent for the publication of the study findings.
: The authors declare that they have no cometing interests.